APA (7th ed.) Citation

Tuan, J. J., Sharma, M., Kayani, J., Davis, M. W., McManus, D., Topal, J. E., & Ogbuagu, O. (2023). Outcomes of pregnant women exposed to Sotrovimab for the treatment of COVID-19 in the BA.1 Omicron predominant era (PRESTO). BMC infectious diseases, 23(1), 258-5. https://doi.org/10.1186/s12879-023-08198-9

Chicago Style (17th ed.) Citation

Tuan, Jessica J., Manas Sharma, Jehanzeb Kayani, Matthew W. Davis, Dayna McManus, Jeffrey E. Topal, and Onyema Ogbuagu. "Outcomes of Pregnant Women Exposed to Sotrovimab for the Treatment of COVID-19 in the BA.1 Omicron Predominant Era (PRESTO)." BMC Infectious Diseases 23, no. 1 (2023): 258-5. https://doi.org/10.1186/s12879-023-08198-9.

MLA (9th ed.) Citation

Tuan, Jessica J., et al. "Outcomes of Pregnant Women Exposed to Sotrovimab for the Treatment of COVID-19 in the BA.1 Omicron Predominant Era (PRESTO)." BMC Infectious Diseases, vol. 23, no. 1, 2023, pp. 258-5, https://doi.org/10.1186/s12879-023-08198-9.